Development of 18F-Labeled Cyclic Peptides for PET Imaging of STING Expression
Journal of Pharmaceutical Analysis · 2026-10 · 101825
DOI: 10.1016/j.jpha.2026.101825 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical Analysis, 2026-10. Verfasst von Jianyang Fang und 8 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
The stimulator of interferon genes (STING) is a promising target for cancer immunotherapy. Developing chemically well-defined probes capable of selectively recognizing STING and transducing this recognition into quantifiable signals remains challenging. In this study, we developed and evaluated two 18 F-labeled cyclic peptide positron emission tomography (PET) radiotracers, [ 18 F]AlF-FTN-001 and [ 18 F]AlF-FTN-302, derived from the high-affinity STING ligand NNK-2. Their chemical and radiochemical properties were systematically characterized. Molecular docking and dynamics simulations, along with biolayer interferometry (BLI) and cellular uptake assays, confirmed their binding conformation, affinity, and specificity for STING. In vivo evaluation in tumor-bearing mice via PET imaging, biodistribution, and blocking studies revealed that [ 18 F]AlF-FTN-302 exhibited superior overall performance, with excellent stability, strong STING specificity, rapid tumor uptake, and high tumor-to-background contrast. Importantly, tracer uptake correlated with STING expression levels, and blocking studies validated target engagement. In conclusion, this study establishes cyclic peptides as a versatile chemical scaffold for constructing STING-targeted molecular sensors and highlights a rational strategy for tuning probe performance through subtle structural modifications. [ 18 F]AlF-FTN-302 holds significant potential for the noninvasive visualization of STING expression within the tumor microenvironment (TME).
Förderung
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Fang, J., Zhang, J., Meng, L., Lu, H., Hong, K., Zhou, Z., Li, Y., Zhang, X., & Guo, Z. (2026). Development of 18F-Labeled Cyclic Peptides for PET Imaging of STING Expression. Journal of Pharmaceutical Analysis, 101825. https://doi.org/10.1016/j.jpha.2026.101825
Vancouver
Fang J, Zhang J, Meng L, Lu H, Hong K, Zhou Z, et al. Development of 18F-Labeled Cyclic Peptides for PET Imaging of STING Expression. Journal of Pharmaceutical Analysis. 2026:101825. doi:10.1016/j.jpha.2026.101825
BibTeX
@article{Fang2026,
author = {Fang, Jianyang and Zhang, Jingru and Meng, Lingxin and Lu, Huan and Hong, Kaiqi and Zhou, Ziying and Li, Yesen and Zhang, Xianzhong and Guo, Zhide},
title = {Development of 18F-Labeled Cyclic Peptides for PET Imaging of STING Expression},
journal = {Journal of Pharmaceutical Analysis},
year = {2026},
pages = {101825},
doi = {10.1016/j.jpha.2026.101825}
}
EUVIMED